Furthermore, CRISPR/Cas9-mediated excision of the mutation in the Jurkat T-ALL cell line led to full abrogation of TAL1 expression (Mansour et al., 2014). The gene discussed is TAL1; the disease is acute lymphoblastic leukemia.